Transient secondary hypothyroidism and thyroxine binding globulin deficiency in leukemic children during polychemotherapy: an effect of L-asparaginase.
D000293:Adolescent; D000510:Alpha-Globulins / Q000172:deficiency*; D001215:Asparaginase / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003630:Daunorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced*; D007223:Infant; D007945:Leukemia, Lymphoid / Q000188:drug therapy*; D011241:Prednisone / Q000627:therapeutic use; D013975:Thyroxine-Binding Proteins / Q000172:deficiency*; D014750:Vincristine / Q000627:therapeutic use
D000510:Alpha-Globulins; D013975:Thyroxine-Binding Proteins; D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin